BioAmber

BioAmber COO Fabrice Orecchioni named President

BioAmber Inc. (NYSE: BIOA) announced today that Jean-Francois Huc has resigned as President and CEO and Fabrice Orecchioni, the company's COO, has been named President, effective immediately. In his role as COO over the past four years,...

Kennet Brysting appointed General Manager, Gilead Canada

Kennet Brysting has been appointed General Manager of Gilead Sciences Canada, Inc., assuming leadership of Gilead's sixth-largest market. The former General Manager of Gilead Nordics (Sweden, Norway, Denmark, Finland and Iceland), Kennet Brysting also joins...
biosys health

Biosys Appoints Axel Wiest to Board of Directors

Biosys Health UK Limited, a clinical-stage microbiome company dedicated to the development of targeted oral immune therapies that modulate the gut microbiome, initially focused on the treatment of C.difficile infection (“CDI”), is pleased to...
3d4medical

3D4Medical Announces the Appointment of Top Academics to Its Academic Review Board

3D4Medical, the world’s leading developer of ground-breaking 3D medical technology applications, is delighted to announce the appointment of its Academic Review Board. Comprising esteemed leaders from the international academic community, the board will help...
Nativis

Nativis Rounds Out Board of Directors with Appointment of Dr. Una Ryan

Nativis Inc., a clinical stage life science bio-electronic company developing non-invasive, safe and highly effective treatments for cancers and other serious diseases, today announced that Dr. Una Ryan has been appointed to its board...
NObilis

Nobilis Health Corp. appoints David Young as CFO

Nobilis Health Corp. today announced the appointment of Mr. David Young as its Chief Financial Officer.  Mr. Young brings to Nobilis extensive Fortune 500 company executive experience in corporate finance, financial planning, and cost...
Kiadis Pharma

Kiadis Pharma Appoints Jan Feijen As Chief Operations Officer

Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company developing innovative T-cell immunotherapy treatments for blood cancers and inherited blood disorders, today announces the appointment...

Shields Health Solutions Appoints Eric Suchecki to Lead the Business Development Team

Shields Health Solutions, creator of specialty pharmacies for hospitals and health systems nationwide, today announced Eric Suchecki has been appointed to the role of Vice President of Business Development at the company. In his...

Alternate Health Appoints Bryan Korba as Chairman and Chief Executive Officer

Alternate Health Corp. is pleased to announce recent appointments to the Company's Board of Directors and Officers of the Company. The following Directors and Officers have been appointed: Bryan Korba – Chairman and Chief Executive Officer Bryan...

Medherant Announces Appointment of New Chair

 Medherant Ltd., a University of Warwick spin-out developing a novel transdermal drug delivery patch technology, is pleased to announce the appointment of Dr Ken Cunningham as Chair. Dr Cunningham joins Medherant as the company...